<?xml-stylesheet type='text/xsl' href='anzctrTransform.xsl'?>
<ANZCTR_Trial requestNumber="366024">
  <stage>Registered</stage>
  <submitdate>9/06/2016</submitdate>
  <approvaldate>6/07/2016</approvaldate>
  <actrnumber>ACTRN12616000892415</actrnumber>
  <trial_identification>
    <studytitle>Comparison of different volumes of local anesthetic used for fascia iliaca compartment block</studytitle>
    <scientifictitle>Comparison of different volumes of local anesthetic used for fascia iliaca compartment block in patients undergoing elective knee or femur surgery</scientifictitle>
    <utrn />
    <trialacronym />
    <secondaryid>Nil known</secondaryid>
  </trial_identification>
  <conditions>
    <healthcondition>Post-operative pain</healthcondition>
    <healthcondition>Femur disorder requiring surgery</healthcondition>
    <healthcondition>Knee disorder requiring surgery</healthcondition>
    <conditioncode>
      <conditioncode1>Anaesthesiology</conditioncode1>
      <conditioncode2>Pain management</conditioncode2>
    </conditioncode>
    <conditioncode>
      <conditioncode1>Musculoskeletal</conditioncode1>
      <conditioncode2>Other muscular and skeletal disorders</conditioncode2>
    </conditioncode>
  </conditions>
  <interventions>
    <interventions>Three different doses of  % 0.25 bupivacaine (0.3 ml/kg (Group 1),  0.4 ml/kg (Group 2), 0.5 ml/kg (Group 3) will be administered via nerve-block needle during single-shot fascia iliaca compartment block application after finishing lower extremity surgery under general anesthsia by an anesthesiologist</interventions>
    <comparator>Three different doses of  % 0.25 bupivacaine
0.3 ml/kg (Group 1),  
0.4 ml/kg (Group 2), 
0.5 ml/kg (Group 3)</comparator>
    <control>Dose comparison</control>
    <interventioncode>Treatment: Drugs</interventioncode>
  </interventions>
  <outcomes>
    <primaryOutcome>
      <outcome>postoperative pain will be assessed by 100mm(10 cm)  visual analogue scale, </outcome>
      <timepoint>in first 24 hours after completion of block. (0, 1, 2, 4, 6, 12, 24th hour after fascia iliaca compartment block).</timepoint>
    </primaryOutcome>
    <secondaryOutcome>
      <outcome>to evaluate additional analgesic need. cumulative diclofenac sodium doses will be recorded</outcome>
      <timepoint>in first 24 hours after completion of block. (0, 1, 2, 4, 6, 12, 24th hour after fascia iliaca compartment block).</timepoint>
    </secondaryOutcome>
  </outcomes>
  <eligibility>
    <inclusivecriteria>Studies elective knee or femur surgery operations to be done with ASA I-II-III patients between the ages of 18 -80  will be included</inclusivecriteria>
    <inclusiveminage>18</inclusiveminage>
    <inclusiveminagetype>Years</inclusiveminagetype>
    <inclusivemaxage>80</inclusivemaxage>
    <inclusivemaxagetype>Years</inclusivemaxagetype>
    <inclusivegender>Both males and females</inclusivegender>
    <healthyvolunteer>No</healthyvolunteer>
    <exclusivecriteria>ASA IV-V
studies did not approve those,
 abnormal coagulation profile Those with neurologic deficits to be implemented drug history of allergy sufferers,
 pregnant women, dermatological disorders, and those with psychiatric patients suffering from the study will be kept</exclusivecriteria>
  </eligibility>
  <trial_design>
    <studytype>Interventional</studytype>
    <purpose>Treatment</purpose>
    <allocation>Randomised controlled trial</allocation>
    <concealment />
    <sequence />
    <masking />
    <assignment />
    <designfeatures />
    <endpoint />
    <statisticalmethods />
    <masking1 />
    <masking2 />
    <masking3 />
    <masking4 />
    <patientregistry>False</patientregistry>
    <followup />
    <followuptype />
    <purposeobs />
    <duration />
    <selection />
    <timing />
  </trial_design>
  <recruitment>
    <phase>Phase 4</phase>
    <anticipatedstartdate />
    <actualstartdate>1/12/2013</actualstartdate>
    <anticipatedenddate />
    <actualenddate>15/05/2014</actualenddate>
    <samplesize>45</samplesize>
    <actualsamplesize>45</actualsamplesize>
    <recruitmentstatus>Completed</recruitmentstatus>
    <anticipatedlastvisitdate />
    <actuallastvisitdate>15/05/2014</actuallastvisitdate>
    <dataanalysis />
    <withdrawnreason />
    <withdrawnreasonother />
    <recruitmentcountry>,Outside</recruitmentcountry>
    <recruitmentstate />
    <countryoutsideaustralia>
      <country>Turkey</country>
      <state>turkey</state>
    </countryoutsideaustralia>
  </recruitment>
  <sponsorship>
    <primarysponsortype>Individual</primarysponsortype>
    <primarysponsorname>metin KILINC</primarysponsorname>
    <primarysponsoraddress>.Faculty of Medicine, University of Gaziantep, university st. 27310 Sehitkamil Gaziantep </primarysponsoraddress>
    <primarysponsorcountry>Turkey</primarysponsorcountry>
    <fundingsource>
      <fundingtype>Hospital</fundingtype>
      <fundingname> University of Gaziantep</fundingname>
      <fundingaddress>Faculty of Medicine, University of Gaziantep, university st. 27310 Sehitkamil Gaziantep </fundingaddress>
      <fundingcountry>Turkey</fundingcountry>
    </fundingsource>
    <secondarysponsor>
      <sponsortype>None</sponsortype>
      <sponsorname />
      <sponsoraddress />
      <sponsorcountry />
    </secondarysponsor>
  </sponsorship>
  <ethicsAndSummary>
    <summary>In our study, we apply daily routine performed with different local anesthetic volume
 FICB in observing the effectiveness of postoperative analgesia in patients with the most effective  in patients aimed to find suitable local anesthetic volumes.
</summary>
    <trialwebsite />
    <publication />
    <ethicsreview>Approved</ethicsreview>
    <publicnotes />
    <ethicscommitee>
      <ethicname>Ethical Committee of Gaziantep University Hospitals</ethicname>
      <ethicaddress>Gaziantep University, University st. 27310, Sehitkamil, GAziantep</ethicaddress>
      <ethicapprovaldate>19/11/2013</ethicapprovaldate>
      <hrec />
      <ethicsubmitdate>18/10/2013</ethicsubmitdate>
      <ethiccountry>Turkey</ethiccountry>
    </ethicscommitee>
  </ethicsAndSummary>
  <attachment />
  <contacts>
    <contact>
      <title>Dr</title>
      <name>metin kilinc</name>
      <address>Faculty of Medicine, University of Gaziantep, university st. 27310 Sehitkamil Gaziantep Turkey</address>
      <phone>+90,532,4563703</phone>
      <fax />
      <email>drmetin1971@hotmail.com</email>
      <country>Turkey</country>
      <type>Principal Investigator</type>
    </contact>
    <contact>
      <title>Dr</title>
      <name>metin kilinc</name>
      <address>Faculty of Medicine, University of Gaziantep, university st. 27310 Sehitkamil Gaziantep Turkey</address>
      <phone>+90,532,4563703</phone>
      <fax />
      <email>drmetin1971@hotmail.com</email>
      <country>Turkey</country>
      <type>Public Queries</type>
    </contact>
    <contact>
      <title>Dr</title>
      <name>metin kilinc</name>
      <address>Faculty of Medicine, University of Gaziantep, university st. 27310 Sehitkamil Gaziantep Turkey</address>
      <phone>+90,532,4563703</phone>
      <fax />
      <email>drmetin1971@hotmail.com</email>
      <country>Turkey</country>
      <type>Scientific Queries</type>
    </contact>
    <contact>
      <title />
      <name />
      <address />
      <phone />
      <fax />
      <email />
      <country />
      <type>Updating Information</type>
    </contact>
  </contacts>
</ANZCTR_Trial>